Acquisition of Theravance (THRX) Might be Best Option for Glaxo (GSK)
Tweet Send to a Friend
Inevitable approval of two lung-disease drugs Breo and Anoro could make Theravance Inc. (Nasdaq: THRX) ripe for a takeover.
This article: 239 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 239 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
